Clinical Trials
2 trialsNCT00118144 2014-08-21
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00117351 2011-02-17
VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features
Millennium Pharmaceuticals, Inc.
Phase 2 Terminated